Joshua A. Lile, Ph.d.

This Phase 2 study will test whether a once-daily cannabis gummy can help people with obesity lose weight. Forty adults aged 18–65 with a BMI of 30 or higher will receive either the cannabis gummy or a placebo for a set period. The main goal is to measure changes in body weight.…

This trial investigates whether Cobenfy, a medication typically used for schizophrenia, can reduce the rewarding effects of cocaine in people with cocaine use disorder. Over an 11-day inpatient stay, participants receive either Cobenfy or a placebo twice daily, then take part in …